FDA has more than 50 agreements with counterparts in other countries. Some of these go back more than 50 years, while others are quite recent. All are founded on the notion of leveraging: parties to these international cooperative agreements can, through their separate and collective actions, protect consumers in one or both of the partner countries.
The session will focus particularly upon issues with food and drug equivalence agreements, including the recent United States-European Union MRA.